Peptides / Compound guide

Somatropin guide

Somatropin is recombinant human growth hormone.[1] The cited product label lists approved uses in children with growth failure from several causes and in adults with growth hormone deficiency. This page uses that label's subcutaneous half-life and its 12 mg cartridge.

Editorial still life for peptides research guides

ILLUSTRATION / COMPOUND LIBRARY SERIES

At a glance

Regulatory status
Somatropin is an FDA-approved prescription medicine; the cited product label lists approved uses in children with growth failure from several causes and in adults with growth hormone deficiency.[1]
Half-life
3.0 hours (mean, 16 adults with growth hormone deficiency) after subcutaneous injection, per one product's label; 0.4 hours after intravenous dosing in healthy adults.[1]
Route
Subcutaneous, per the label.[1]
Category
Peptides
Vial size
12 mg

Somatropin's 12 mg package is a two-chamber cartridge. That detail prevents the page from assigning a generic vial-water example to it. The three-hour reference is specifically subcutaneous; the label also gives a mean peak time of about 5.9 hours.[1]

What the research says

The cited label describes subcutaneous pharmacokinetic studies in adults with growth hormone deficiency. Investigators measured serum growth hormone after injection and compared systemic availability with intravenous exposure. Approximately 80% bioavailability and a peak around six hours were reported in this defined adult population.[1]

The source reports a three-hour half-life after subcutaneous administration in growth-hormone-deficient adults, compared with about 0.4 hours after intravenous administration in healthy adults. It attributes the longer subcutaneous time course to slow absorption from the injection site. Both route and population accompany those estimates.[1]

The label also compares exposure from different solution concentrations in adults and children. It explicitly states that bioequivalence data are unavailable between the 12 mg/mL formulation and two other studied concentrations. The 12 mg cartridge package is verified independently of assuming all formulations share identical exposure.[1]

Cited amounts

The label describes 12 mg in a single-patient-use two-chamber cartridge (it also lists a 5 mg cartridge). This is the total in that presentation, not an amount selected for administration. No personal dosing range is inferred from it.[1]

Open the calculator for amount conversions

Half-life and timing

3.0 hours (mean, 16 adults with growth hormone deficiency) after subcutaneous injection, per one product's label; 0.4 hours after intravenous dosing in healthy adults.[1]

With three hours as its scalar, the model reaches one quarter at six hours and one thirty-second at 15 hours. The source's mean peak time of about 5.9 hours describes another process and is not substituted for the half-life. The simple bar begins with an abstract starting amount instead of modeling cartridge preparation or absorption after administration. Its 15-hour endpoint does not measure the duration of a hormone response, establish complete personal clearance, or suggest a schedule for recording another amount.

Somatropin: modeled fraction over five half-livesStarting at 100 percent, the model halves each 3 hours. After 15 hours, 3.125 percent remains. This is arithmetic, not a measured concentration. ELAPSED HOURS / MODELED STARTING AMOUNT 0 h100%3 h50%6 h25%9 h12.5%12 h6.25%15 h3.125% Continue to the calculator

Reconstitution

The label states that the 12 mg two-chamber cartridge, once reconstituted in its pen, contains 12 mg/mL with a deliverable volume of 1 mL. Follow the cartridge and pen instructions for preparation. Package-count arithmetic is still possible: two such cartridges contain 24 mg in total. These totals describe stock, not amounts selected for administration.[1]

2 cartridges × 12 mg = 24 mg
Open Somatropin conversion math

Tracking it in PinPoint

From a reference to a record

Built for peptide, TRT, and GLP-1 schedules. Set up your vial in seconds, log every dose, and see your modeled levels between doses. Track vials and prefilled pens side by side.[2]

The Home curve models your levels between doses from an estimate built on the half-life value stored for each compound, published where a published value exists and an estimate where none does. Drag to scrub modeled values at any timestamp, or preview 30 days of a dose pattern. Ask PinPoint provides educational reference with sources; it never recommends a dose or a schedule change. These features record and visualize entered information, with the limits of each compound's source data still applying.

Get PinPoint on the App Store

Frequently asked questions

What is HGH in this peptide library?
This guide uses somatropin for the recombinant human growth hormone entry. The cited product label reports a 3.0-hour half-life after subcutaneous injection in adults with growth hormone deficiency and supplies a 12 mg two-chamber cartridge. For growth hormone secretagogues, see the GHRP-2 and sermorelin pages.[1]
What concentration does the 12 mg somatropin cartridge give?
The label states 12 mg/mL after reconstitution, with a deliverable volume of 1 mL.[1]

Sources

Sources checked against the cited documents on 19 November 2026.

  1. Somatropin for injection, two-chamber cartridge, prescribing information (DailyMed, revised July 2026)Read 19 November 2026: 1, 3 Dosage forms, 11 Description, 12.3 and Table 2, 16.1. Figures are for this one product.Retrieved 2026-11-19 · label
  2. PinPoint App Store descriptionFeature wording from the approved application description, not pricing.Retrieved 2026-10-05 · app-description